496 related articles for article (PubMed ID: 8318817)
1. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
2. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
3. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
Miller SC; Christopher FL; Dussault I
Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521
[TBL] [Abstract][Full Text] [Related]
4. Effect on leukemia cell numbers of in vivo administration of immunotherapeutic agents is age-dependent.
Dussault I; Miller SC
Oncology; 1996; 53(3):241-6. PubMed ID: 8643228
[TBL] [Abstract][Full Text] [Related]
5. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
Saarloos MN; Khoo NK; Lala PK
Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice.
Johnson CS; Thurlow SM; Furmanski P
Leukemia; 1989 Feb; 3(2):91-6. PubMed ID: 2783472
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of immunotherapy in aged leukemic mice.
Dussault I; Miller SC
Gerontology; 1995; 41(4):195-204. PubMed ID: 7557496
[TBL] [Abstract][Full Text] [Related]
8. Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice.
Whyte AL; Miller SC
Immunobiology; 1998 Jul; 199(1):23-38. PubMed ID: 9717665
[TBL] [Abstract][Full Text] [Related]
9. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J
Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654
[TBL] [Abstract][Full Text] [Related]
11. Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span.
Currier NL; Miller SC
J Altern Complement Med; 2001 Jun; 7(3):241-51. PubMed ID: 11439845
[TBL] [Abstract][Full Text] [Related]
12. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
13. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
Lauria F; Raspadori D; Ventura MA; Rondelli D; Zinzani PL; Gherlinzoni F; Miggiano MC; Fiacchini M; Rosti G; Rizzi S; Tura S
Bone Marrow Transplant; 1996 Jul; 18(1):79-85. PubMed ID: 8831999
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
[TBL] [Abstract][Full Text] [Related]
15. Decline in natural killer cell-mediated immunosurveillance in aging mice--a consequence of reduced cell production and tumor binding capacity.
Dussault I; Miller SC
Mech Ageing Dev; 1994 Aug; 75(2):115-29. PubMed ID: 7823634
[TBL] [Abstract][Full Text] [Related]
16. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
17. Induction of natural killer cell activity in mice by injection of indomethacin.
Voth R; Chmielarczyk W; Storch E; Kirchner H
Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
[TBL] [Abstract][Full Text] [Related]
18. Distinct antitumor mechanisms of recombinant interleukin-2 on recombinant interleukin-2-activated killer-sensitive and -resistant murine tumors.
Maekawa R; Kitagawa T; Koizumi K; Sato K; Homma M
J Biol Response Mod; 1989 Dec; 8(6):676-90. PubMed ID: 2600605
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
20. Effects of rIL-7 on murine bone marrow NK precursor cells.
Pollack SB; Tsuji J
Cell Immunol; 1993 Oct; 151(1):1-11. PubMed ID: 8402921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
